INVESTMENT SECURITIES, RELATED PARY (Tables)

9 Months Ended

Jun. 30, 2022

Investment Securities Related Pary

Schedule of dividend income

Fair Value of Intellectual Property	$	1,500
Prepaid Expenses		65,661
Due from Employee		1,071
Note Receivable		64,400
Accrued Interest Receivable		23,989
Investment Securities		8,423,366
Convertible Note Receivable		10,000
Accounts Payable		1,269,041
Notes Payable		400,000
Accrued Expenses Related Parties		162,011
Notes Payable Related Party		5396
Accrued Expenses		203,037
Enterprise Value		10,563,930
Less: Total Debt		(2,038,343	)
Portion of Enterprise Value Attributable to Shareholders		8,525,587
Fair Value  Per Share	$	0.186168

Schedule of comprehensive income

Basis		Fair Value		Total Unrealized Gains		Net Unrealized Gain or (Loss) realized during the quarter   ended June 30,2022
$	5,741	$	87,608	$	81,867	$	79,749

  725,000 Series M Preferred of Zander Therapeutics, Inc.

Basis		Fair Value		Total Unrealized Gain		Net Unrealized Gain or (Loss) realized during the quarter  ended June 30, 2022
$	$13,124	$	134,971	$	121,847	$	122,861